L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,337	3,835	5,047	7,395	16,108	4,910
Short-Term Investments	13,608	16,108	7,729	5,608	3,108	3,306
Cash & Short-Term Investments	17,945	19,943	12,776	13,003	19,216	8,216
Cash Growth	171.88%	56.10%	-1.75%	-32.33%	133.88%	68.81%
Accounts Receivable	15,894	14,980	9,839	5,780	1,526	3,084
Other Receivables	342.91	290.26	1,066	223.05	635.92	203.53
Receivables	16,601	16,015	10,905	6,003	2,162	3,309
Inventory	27,797	24,551	19,089	16,366	13,856	19,358
Prepaid Expenses	729.37	525.95	656.55	444.63	688.1	310.2
Other Current Assets	2,075	2,532	990.85	330.62	2,042	851.06
Total Current Assets	65,148	63,566	44,417	36,147	37,964	32,044
Property, Plant & Equipment	9,864	10,005	9,012	8,514	9,271	7,890
Long-Term Investments	577.5	577.5	1,049	64.15	1,203	1,755
Goodwill	-	-	-	-	-	244.11
Other Intangible Assets	999.08	998.17	798.73	715.11	1,209	836.23
Long-Term Accounts Receivable	1,886	1,807	1,281	2,385	5,200	5,006
Long-Term Deferred Tax Assets	5,037	5,009	5,516	3,902	3,591	8,515
Long-Term Deferred Charges	-	-	-	106.09	223.63	427.86
Other Long-Term Assets	1,519	798.55	387.38	829.96	623.29	2,278
Total Assets	85,330	83,061	62,762	52,663	59,285	58,995
Accounts Payable	3,060	3,347	2,047	2,437	498.73	1,384
Accrued Expenses	750.77	851.44	685.87	589.86	606.95	791.83
Short-Term Debt	20,966	20,558	10,040	20,406	6,692	12,434
Current Portion of Long-Term Debt	800	800	100	2,800	-	3,128
Current Portion of Leases	938.85	669.07	828.69	750.57	636.63	572.79
Current Income Taxes Payable	9.26	7.29	0.35	54.09	0.89	3.59
Other Current Liabilities	13,278	12,841	9,062	10,943	4,177	1,350
Total Current Liabilities	39,802	39,074	22,763	37,981	12,613	19,664
Long-Term Debt	1,000	1,000	1,700	-	13,608	2,100
Long-Term Leases	478.63	369.63	845.16	1,244	1,518	1,751
Long-Term Deferred Tax Liabilities	1,458	1,569	1,361	1,047	-	-
Other Long-Term Liabilities	2,103	1,958	3,274	55.37	5,429	54.28
Total Liabilities	48,025	47,028	32,175	41,902	34,499	24,832
Common Stock	9,968	9,968	9,968	6,703	6,696	6,635
Additional Paid-In Capital	56,477	90,386	90,386	68,174	67,992	63,616
Retained Earnings	-25,442	-58,746	-67,849	-65,348	-51,884	-40,051
Treasury Stock	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09
Comprehensive Income & Other	2,905	887.93	2,846	2,740	1,663	1,415
Total Common Equity	43,908	42,496	35,351	12,268	24,467	31,615
Minority Interest	-6,603	-6,463	-4,764	-1,507	319.82	2,548
Shareholders' Equity	37,305	36,033	30,587	10,762	24,787	34,163
Total Liabilities & Equity	85,330	83,061	62,762	52,663	59,285	58,995
Total Debt	24,183	23,397	13,513	25,201	22,456	19,986
Net Cash (Debt)	-6,238	-3,454	-737.76	-12,198	-3,240	-11,770
Net Cash Per Share	-289.99	-160.55	-45.50	-910.57	-242.05	-989.82
Filing Date Shares Outstanding	19.94	19.94	19.94	13.41	13.39	13.24
Total Common Shares Outstanding	19.94	19.94	19.94	13.41	13.39	13.27
Working Capital	25,346	24,492	21,654	-1,834	25,351	12,380
Book Value Per Share	2202.38	2131.56	1773.17	915.17	1826.89	2382.37
Tangible Book Value	42,909	41,498	34,553	11,553	23,258	30,534
Tangible Book Value Per Share	2152.27	2081.50	1733.11	861.82	1736.61	2300.96
Land	737.02	737.02	737.02	737.02	737.02	1,079
Buildings	2,502	2,502	2,502	2,502	2,502	3,682
Machinery	15,405	16,491	14,307	12,330	11,671	5,884
Construction In Progress	59	59	-	-	-	225.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.